*ST赛隆 (002898)

Sailong Pharmaceutical Group Co., Ltd.

ASZ

Tags

Special Treatment (ST) SectorEast Data West ComputingInnovative DrugsPharmaceutical ManufacturingHelicobacter PyloriControl ChangeHepatitis Concept

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 17600.00
  • Circulating A-Shares(W): 10126.26
  • Earnings Per Share(RMB): -0.2295
  • Net Assets Per Share(RMB): 2.6163
  • Operating Revenue(W RMB): 20002.15
  • Total Profit(W RMB): -3880.24
  • Net Profit Attributable to Parent(W RMB): -4039.81
  • Net Profit Growth Rate(%): -993.92
  • Weighted Return on Equity(%): -8.4300
  • Operating Cash Flow Per Share(RMB): -0.2090
  • Undistributed Profit Per Share(RMB): -0.1344
  • Capital Reserve Per Share(RMB): 1.6390

2. Main Business

The main business covers:

  • Research, development, production, marketing and technical services of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations.

3. Company Basic Information

  • Company Name: Sailong Pharmaceutical Group Co., Ltd.
  • Listing Date: 2017-09-12
  • Industry: Pharmaceutical Manufacturing
  • Address: 21/F, Unit 2, No. 31 Nanwan North Road, Xiangzhou District, Zhuhai City, Guangdong Province, China
  • Website: www.sailong.cn
  • Company Profile: The issuer was restructured from Zhuhai Sailong Pharmaceutical Co., Ltd. based on its audited net asset value of RMB 37,790,370.97 as of September 30, 2014. After deducting RMB 15,000,000 for cash dividends, the remaining net assets of RMB 22,790,370.97 were converted into shares to establish Zhuhai Sailong Pharmaceutical Co., Ltd. as a joint-stock company, with 5 million shares issued and the remaining RMB 17,790,370.97 recorded as capital reserve. The shareholding ratios of all promoters remained unchanged before and after the restructuring. On December 11, 2014, Grant Thornton Certified Public Accountants (Special General Partnership) conducted the capital verification for the establishment of the joint-stock company and issued the Grant Thornton Capital Verification Report (Grant Thornton Capital Verification No. (2014) 110ZA0362). On December 22, 2014, the company obtained the Business License of Legal Person (Registration No. 440400000086623) from the Zhuhai Administration for Industry and Commerce.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hainan Yayi Win-Win Technology Partnership (Limited Partnership) General Legal Person 2491.22 24.60
2 Zhuhai Hengqin New Area Sailong Juzhi Investment Co., Ltd. General Legal Person 1275.63 12.60
3 MERRILL LYNCH INTERNATIONAL QFII 66.39 0.66

5. Concept Sectors

  • ST Sector
  • Helicobacter Pylori
  • East Data West Computing
  • Hepatitis Concept
  • Innovative Drug
  • Control Change

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information